Cargando…
IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Scientific Publishers
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164589/ http://dx.doi.org/10.1016/j.diabres.2022.109338 |
| _version_ | 1784720169137864704 |
|---|---|
| author | Ruge, M. Sriram, U. Gomez, J.M.D. Du Fay De Lavallaz, J. Gajo, E. Sarau, A. Simmons, J.A. Volgman, A.S. Suboc, T. |
| author_facet | Ruge, M. Sriram, U. Gomez, J.M.D. Du Fay De Lavallaz, J. Gajo, E. Sarau, A. Simmons, J.A. Volgman, A.S. Suboc, T. |
| author_sort | Ruge, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9164589 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Scientific Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91645892022-06-04 IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 Ruge, M. Sriram, U. Gomez, J.M.D. Du Fay De Lavallaz, J. Gajo, E. Sarau, A. Simmons, J.A. Volgman, A.S. Suboc, T. Diabetes Res Clin Pract Article Elsevier Scientific Publishers 2022-04 2022-06-03 /pmc/articles/PMC9164589/ http://dx.doi.org/10.1016/j.diabres.2022.109338 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ruge, M. Sriram, U. Gomez, J.M.D. Du Fay De Lavallaz, J. Gajo, E. Sarau, A. Simmons, J.A. Volgman, A.S. Suboc, T. IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title | IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title_full | IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title_fullStr | IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title_full_unstemmed | IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title_short | IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 |
| title_sort | idf21-0311 pre-admission, diabetic glycemic control on 60-day mortality and major adverse cardiovascular events from covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164589/ http://dx.doi.org/10.1016/j.diabres.2022.109338 |
| work_keys_str_mv | AT rugem idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT sriramu idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT gomezjmd idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT dufaydelavallazj idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT gajoe idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT saraua idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT simmonsja idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT volgmanas idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 AT suboct idf210311preadmissiondiabeticglycemiccontrolon60daymortalityandmajoradversecardiovasculareventsfromcovid19 |